quinoxalines has been researched along with Erythrocytosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baffert, F; Blasco, F; Brueggen, J; Chène, P; De Pover, A; Drueckes, P; Erdmann, D; Furet, P; Gerspacher, M; Hofmann, F; Lang, M; Ledieu, D; Nolan, L; Pissot-Soldermann, C; Radimerski, T; Régnier, CH; Ruetz, S; Tavares, GA; Trappe, J; Vangrevelinghe, E; Wartmann, M; Wyder, L | 1 |
1 other study(ies) available for quinoxalines and Erythrocytosis
Article | Year |
---|---|
Potent and selective inhibition of polycythemia by the quinoxaline JAK2 inhibitor NVP-BSK805.
Topics: Adenosine Triphosphate; Animals; Apoptosis; Cell Line; Cell Line, Tumor; Cell Proliferation; Erythropoiesis; Humans; Janus Kinase 2; K562 Cells; Mice; Mice, Inbred BALB C; Mice, SCID; Models, Molecular; Molecular Structure; Mutation; Phosphorylation; Polycythemia; Protein Structure, Tertiary; Quinoxalines; Rats; Splenomegaly; STAT5 Transcription Factor | 2010 |